Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation
Author(s) -
Sagar S. Patel,
Lisa Rybicki,
Melissa Yurch,
Dawn Thomas,
Hien Liu,
Robert M. Dean,
Deepa Jagadeesh,
Brian T. Hill,
Brad Pohlman,
Brian J. Bolwell,
Rabi Hanna,
Betty K. Hamilton,
Matt Kalaycio,
Aaron T. Gerds,
Eric Cober,
Sherif B. Mossad,
Aiwen Zhang,
Navneet S. Majhail,
Medhat Askar,
Ronald Sobecks
Publication year - 2019
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2019.10.001
Subject(s) - immunology , histocompatibility , transplantation , hematopoietic stem cell transplantation , major histocompatibility complex , disease , cytomegalovirus , gene , minor histocompatibility antigen , hematopoietic cell , biology , human leukocyte antigen , medicine , haematopoiesis , genetics , virology , stem cell , viral disease , herpesviridae , virus , antigen , pathology
Cytomegalovirus (CMV) infection and disease are common infectious complications after allogeneic hematopoietic cell transplantation (alloHCT). Major histocompatibility complex (MHC) class I chain-related gene A (MICA) is a ligand of the natural killer (NKG2D) receptor on immune effector cells that helps mediate NK cell alloreactivity. We hypothesized that MICA polymorphisms may influence CMV infection and disease incidence after alloHCT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom